Advertisements

ImmunoCellular Therapeutics Ltd. (IMUC) Stock Quote

Detailed Quote for ImmunoCellular Therapeutics Ltd. (IMUC)
$ 0.2871   -0.0059 (-2.01%) Volume: 726.9k 4:00 PM EST Jan 18, 2018
After Hours:  $ 0.2855   -0.0016 (-0.56%) Volume: 6.29k 5:27 PM EST Jan 18, 2018
Today 5d 1m 3m 1y more
Last Price
0.2871
Change $
0.0059
Change %
2.01%
Tick
  
Bid
0.285
Bid Size
1,500
Ask
0.35
Ask Size
3,000
Open
0.31
High
0.31
Low
0.284
Prev Close
0.293
Last Trade
01/18/18
Volume
726.9k
52 Wk Hi
3.68000006
52 Wk Low
0.170000001
Market Cap
10.1m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
35,195,343
EPS (TTM)
-4.76000022
PE Ratio
N/A
Exchange
NYSE American
News and Media for ImmunoCellular Therapeutics Ltd. (IMUC)
Sector News | Topic News
News for ImmunoCellular Therapeutics Ltd. (IMUC)
Fri, Dec 22, 2017
11:00 AM 2017 YTD worst losers - healthcare - SeekingAlpha
Fri, Dec 15, 2017
8:20 AM Today's Research Reports on Trending Tickers: ImmunoCellular Therapeutics and Marinus Pharmaceuticals - ACCESSWIRE IA
Wed, Dec 13, 2017
10:49 PM ImmunoCellular Therapeutics +158% on immuno-oncology milestone - SeekingAlpha
4:05 PM ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program - PR Newswire
Wed, Nov 22, 2017
8:43 AM Your Daily Pharma Scoop: Teva Valuation, DelMar Lead Candidate, Galapagos Commences Trial - SeekingAlpha
6:00 AM ImmuncoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 - PR Newswire
Tue, Nov 21, 2017
7:10 PM ImmunoCellular Therapeutics' (IMUC) CEO Anthony Gringeri on Q3 2017 Results - Earnings Call Transcript - SeekingAlpha
4:10 PM ImmunoCellular Therapeutics reports Q3 results - SeekingAlpha
4:05 PM ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results - PR Newswire
Fri, Nov 17, 2017
6:00 AM ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 - PR Newswire
Wed, Nov 08, 2017
8:30 AM Market Trends Toward New Normal in ONEOK, ServiceNow, Mirati, ImmunoCellular, United Technologies, and USG - Emerging Consolidated Expectations, Analyst Ratings - GlobeNewswire
Thu, Oct 12, 2017
2:19 PM ImmunoCellular Therapeutics (IMUC) Presents At Lytham Partners Virtual Investor Conference - Slideshow - SeekingAlpha
Tue, Oct 03, 2017
6:00 AM ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET - PR Newswire
Tue, Sep 19, 2017
8:00 AM ImmunoCellular, Innovative Cellular Platform, and Pipeline Review - ACCESSWIRE IA
Wed, Sep 13, 2017
4:05 PM ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance - PR Newswire
Wed, Aug 23, 2017
4:30 PM ImmunoCellular committed to Stem-to-T-Cell program; reductions in facilities and jobs planned as is additional financing - SeekingAlpha
4:05 PM ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy - PR Newswire
Mon, Aug 14, 2017
6:02 PM ImmunoCellular Therapeutics reports Q2 results - SeekingAlpha
6:00 PM ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results - PR Newswire
Wed, Jul 19, 2017
8:11 AM Today's Research Reports on Stocks to Watch: Capricor Therapeutics and Immunocellular Therapeutics - ACCESSWIRE IA
More News for IMUC >>

Tags for ImmunoCellular Therapeutics Ltd.

Research stocks or mutual funds related to ImmunoCellular Therapeutics Ltd. by keywords or tags. Find companies that have a similar focus to IMUC. The keywords below have been associated to IMUC by either user submission or electronic means.

Surgical and Medical Instrument Manufacturing (339112) Healthcare Common Stock Health Services Surgical And Medical Instruments And Apparatus (3841)